About Ozempic & Wegovy Lawsuit
Ozempic and Wegovy, both containing the active ingredient semaglutide, have become extremely popular for weight loss and diabetes management. However, thousands of patients report severe side effects not adequately disclosed in medication labeling. These include thyroid cancer risk, pancreatitis, gastroparesis, acute kidney injury, and serious psychiatric symptoms including suicidal thoughts.
Animal studies have shown that semaglutide increases thyroid cancer risk, yet Novo Nordisk placed this warning in the prescribing information with inadequate prominence. Patients taking Ozempic or Wegovy were not properly warned about pancreatitis risk, which can cause permanent organ damage. Additionally, many patients report that psychiatric side effects were not adequately warned about.
While some patients benefit from these medications, those who suffered serious harm may have claims against Novo Nordisk for failure to warn and product defect. If you took Ozempic or Wegovy and developed thyroid cancer, pancreatitis, or other serious health problems, you may be eligible for compensation.